(secondQuint)Safety and Tolerability of 4975 in the Treatment of Moderate to Severe Knee Pain Due to Osteoarthritis (OA).

 This is a single site study.

 The study drug, 4975, will be administered in various dosing regimens by intra-articular injection followed by an observation period of up to 12 weeks.

 Pain in the treated knee will be assessed before, during and after administration of the study drug.

.

 Safety and Tolerability of 4975 in the Treatment of Moderate to Severe Knee Pain Due to Osteoarthritis (OA)@highlight

This study will evaluate dosing regimens of 4975 in terms of safety and tolerability when delivered as an intra-articular injection in the knee.

 Secondary objectives will be to explore the efficacy of 4975 in terms of onset, extent and duration of pain relief.

